Psychological and Behavioral Effects of GLP-1 and GIP Drugs: Beyond Physical Health

Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addiction, cognition, and mental health implications of these metabolic drugs.

Ameer, Fatima et al.·Journal of diabetes and metabolic disorders·2025·Moderate EvidenceReview
RPEP-09921ReviewModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
N=not applicable
Participants
Review covering GLP-1/GIP drug users across psychological and behavioral studies

What This Study Found

Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addiction, cognition, and mental health implications of these metabolic drugs.

Key Numbers

Review covers tirzepatide as a dual GLP-1/GIP agonist and its effects on insulin secretion, appetite regulation, and brain reward circuits.

How They Did This

In publication.

Why This Research Matters

Relevant to peptide therapeutics.

The Bigger Picture

Advances peptide therapeutic knowledge.

What This Study Doesn't Tell Us

In publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addic
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review.
Published In:
Journal of diabetes and metabolic disorders, 24(2), 253 (2025)
Database ID:
RPEP-09921

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Review of psychological and behavioral effects of GLP-1/GIP agonists covers mood, food reward, addiction, cognition, and mental health implications of these metabolic drugs.

How reliable?

Consult publication.

Read More on RethinkPeptides

Cite This Study

RPEP-09921·https://rethinkpeptides.com/research/RPEP-09921

APA

Ameer, Fatima; Villacres, Nicole Yañez; Bustos, Daniel; Shah, Pari C; Appah, Noble; Luzaya, Galilee N; Corradi, Francesca; Bakare, Ifeoluwa S; Trujillo, Juan D; Mylavarapu, Maneeth; Mowo-Wale, Adetola; Silva, Alisson Barbosa. (2025). Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review.. Journal of diabetes and metabolic disorders, 24(2), 253. https://doi.org/10.1007/s40200-025-01770-x

MLA

Ameer, Fatima, et al. "Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review.." Journal of diabetes and metabolic disorders, 2025. https://doi.org/10.1007/s40200-025-01770-x

RethinkPeptides

RethinkPeptides Research Database. "Psychological and behavioral effects of GLP-1 and GIP agonis..." RPEP-09921. Retrieved from https://rethinkpeptides.com/research/ameer-2025-psychological-and-behavioral-effects

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.